questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Transferases
Acyltransferases
Acetyltransferases
N-terminal acetyltransferases
N-terminal acetyltransferases : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "N-terminal acetyltransferases : Questions médicales les plus fréquentes",
"headline": "N-terminal acetyltransferases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les N-terminal acetyltransferases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-08",
"dateModified": "2025-03-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "N-terminal acetyltransferases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Acetyltransferases",
"url": "https://questionsmedicales.fr/mesh/D000123",
"about": {
"@type": "MedicalCondition",
"name": "Acetyltransferases",
"code": {
"@type": "MedicalCode",
"code": "D000123",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.050.134"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "N-terminal acetyltransferase A",
"alternateName": "N-Terminal Acetyltransferase A",
"url": "https://questionsmedicales.fr/mesh/D063209",
"about": {
"@type": "MedicalCondition",
"name": "N-terminal acetyltransferase A",
"code": {
"@type": "MedicalCode",
"code": "D063209",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.050.134.423.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "N-terminal acetyltransferase B",
"alternateName": "N-Terminal Acetyltransferase B",
"url": "https://questionsmedicales.fr/mesh/D063210",
"about": {
"@type": "MedicalCondition",
"name": "N-terminal acetyltransferase B",
"code": {
"@type": "MedicalCode",
"code": "D063210",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.050.134.423.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "N-terminal acetyltransferase C",
"alternateName": "N-Terminal Acetyltransferase C",
"url": "https://questionsmedicales.fr/mesh/D063211",
"about": {
"@type": "MedicalCondition",
"name": "N-terminal acetyltransferase C",
"code": {
"@type": "MedicalCode",
"code": "D063211",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.050.134.423.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "N-terminal acetyltransferase D",
"alternateName": "N-Terminal Acetyltransferase D",
"url": "https://questionsmedicales.fr/mesh/D063212",
"about": {
"@type": "MedicalCondition",
"name": "N-terminal acetyltransferase D",
"code": {
"@type": "MedicalCode",
"code": "D063212",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.050.134.423.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "N-terminal acetyltransferase E",
"alternateName": "N-Terminal Acetyltransferase E",
"url": "https://questionsmedicales.fr/mesh/D063213",
"about": {
"@type": "MedicalCondition",
"name": "N-terminal acetyltransferase E",
"code": {
"@type": "MedicalCode",
"code": "D063213",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.050.134.423.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "N-terminal acetyltransferase F",
"alternateName": "N-Terminal Acetyltransferase F",
"url": "https://questionsmedicales.fr/mesh/D063214",
"about": {
"@type": "MedicalCondition",
"name": "N-terminal acetyltransferase F",
"code": {
"@type": "MedicalCode",
"code": "D063214",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.050.134.423.600"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "N-terminal acetyltransferases",
"alternateName": "N-Terminal Acetyltransferases",
"code": {
"@type": "MedicalCode",
"code": "D063206",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Thomas Arnesen",
"url": "https://questionsmedicales.fr/author/Thomas%20Arnesen",
"affiliation": {
"@type": "Organization",
"name": "Department of Biological Sciences, University of Bergen, Bergen, Norway."
}
},
{
"@type": "Person",
"name": "Ronen Marmorstein",
"url": "https://questionsmedicales.fr/author/Ronen%20Marmorstein",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Pennsylvania, Philadelphia, PA, United States; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States; Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States. Electronic address: marmor@upenn.edu."
}
},
{
"@type": "Person",
"name": "Sunbin Deng",
"url": "https://questionsmedicales.fr/author/Sunbin%20Deng",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States."
}
},
{
"@type": "Person",
"name": "Antonis Kirmizis",
"url": "https://questionsmedicales.fr/author/Antonis%20Kirmizis",
"affiliation": {
"@type": "Organization",
"name": "Epigenetics and Gene Regulation Laboratory, Department of Biological Sciences, University of Cyprus, Nicosia 2109, Cyprus."
}
},
{
"@type": "Person",
"name": "Henriette Aksnes",
"url": "https://questionsmedicales.fr/author/Henriette%20Aksnes",
"affiliation": {
"@type": "Organization",
"name": "Department of Biomedicine, University of Bergen, Bergen, Norway. Electronic address: henriette.aksnes@uib.no."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Use of machine learning and deep learning to predict particulate",
"datePublished": "2023-09-15",
"url": "https://questionsmedicales.fr/article/37716314",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jenvrad.2023.107294"
}
},
{
"@type": "ScholarlyArticle",
"name": "A deep learning model for anti-inflammatory peptides identification based on deep variational autoencoder and contrastive learning.",
"datePublished": "2024-08-08",
"url": "https://questionsmedicales.fr/article/39117712",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-69419-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Deep Learning Subtraction Angiography: Improved Generalizability with Transfer Learning.",
"datePublished": "2022-12-16",
"url": "https://questionsmedicales.fr/article/36529442",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jvir.2022.12.008"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Machine Learning and Deep Learning Approach for Recognizing Handwritten Digits.",
"datePublished": "2022-07-15",
"url": "https://questionsmedicales.fr/article/35875749",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/9869948"
}
},
{
"@type": "ScholarlyArticle",
"name": "Editorial of Special Issue \"Deep Learning and Machine Learning in Bioinformatics\".",
"datePublished": "2022-06-14",
"url": "https://questionsmedicales.fr/article/35743052",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms23126610"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Transferases",
"item": "https://questionsmedicales.fr/mesh/D014166"
},
{
"@type": "ListItem",
"position": 5,
"name": "Acyltransferases",
"item": "https://questionsmedicales.fr/mesh/D000217"
},
{
"@type": "ListItem",
"position": 6,
"name": "Acetyltransferases",
"item": "https://questionsmedicales.fr/mesh/D000123"
},
{
"@type": "ListItem",
"position": 7,
"name": "N-terminal acetyltransferases",
"item": "https://questionsmedicales.fr/mesh/D063206"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : N-terminal acetyltransferases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur N-terminal acetyltransferases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur N-terminal acetyltransferases",
"description": "Comment diagnostiquer une déficience en N-terminal acetyltransferases ?\nQuels tests sont utilisés pour évaluer l'activité des N-terminal acetyltransferases ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels marqueurs biologiques indiquent une activité anormale ?\nPeut-on utiliser l'imagerie pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D063206?mesh_terms=Deep+Learning&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur N-terminal acetyltransferases",
"description": "Quels symptômes sont associés à une déficience en N-terminal acetyltransferases ?\nLes symptômes varient-ils selon le type d'enzyme affectée ?\nY a-t-il des symptômes cutanés associés ?\nLes troubles cognitifs sont-ils liés à ces enzymes ?\nLes symptômes apparaissent-ils dès la naissance ?",
"url": "https://questionsmedicales.fr/mesh/D063206?mesh_terms=Deep+Learning&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur N-terminal acetyltransferases",
"description": "Peut-on prévenir les déficiences en N-terminal acetyltransferases ?\nLes conseils génétiques sont-ils recommandés ?\nL'alimentation peut-elle jouer un rôle préventif ?\nDes dépistages réguliers sont-ils conseillés ?\nLes vaccinations peuvent-elles aider ?",
"url": "https://questionsmedicales.fr/mesh/D063206?mesh_terms=Deep+Learning&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur N-terminal acetyltransferases",
"description": "Quels traitements sont disponibles pour les déficiences en N-terminal acetyltransferases ?\nLes suppléments nutritionnels peuvent-ils aider ?\nLa thérapie génique est-elle une option ?\nLes médicaments peuvent-ils améliorer la fonction enzymatique ?\nY a-t-il des traitements symptomatiques disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D063206?mesh_terms=Deep+Learning&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur N-terminal acetyltransferases",
"description": "Quelles complications peuvent survenir avec ces déficiences ?\nLes complications sont-elles réversibles ?\nY a-t-il un risque accru de maladies associées ?\nLes complications affectent-elles la qualité de vie ?\nDes soins palliatifs sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D063206?mesh_terms=Deep+Learning&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur N-terminal acetyltransferases",
"description": "Quels sont les facteurs de risque pour ces déficiences ?\nL'âge joue-t-il un rôle dans le risque ?\nLes facteurs environnementaux influencent-ils le risque ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nLe sexe a-t-il un impact sur le risque ?",
"url": "https://questionsmedicales.fr/mesh/D063206?mesh_terms=Deep+Learning&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en N-terminal acetyltransferases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses protéomiques peuvent identifier des anomalies."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des N-terminal acetyltransferases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques mesurant l'acétylation des substrats spécifiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles nécessaires pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, mais elles peuvent être utiles pour des analyses plus approfondies."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques indiquent une activité anormale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux de protéines acétylées peuvent indiquer une dysfonction enzymatique."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser l'imagerie pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie n'est pas couramment utilisée pour diagnostiquer des troubles enzymatiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à une déficience en N-terminal acetyltransferases ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des troubles neurologiques et des anomalies métaboliques."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type d'enzyme affectée ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque enzyme a des substrats spécifiques, entraînant des symptômes variés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines déficiences peuvent provoquer des éruptions cutanées ou des anomalies dermatologiques."
}
},
{
"@type": "Question",
"name": "Les troubles cognitifs sont-ils liés à ces enzymes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles cognitifs peuvent survenir en raison de l'impact sur le métabolisme neuronal."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils dès la naissance ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, certains symptômes peuvent se développer plus tard dans l'enfance ou l'adolescence."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les déficiences en N-terminal acetyltransferases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un diagnostic précoce peut aider à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Les conseils génétiques sont-ils recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les conseils génétiques peuvent être utiles pour les familles à risque."
}
},
{
"@type": "Question",
"name": "L'alimentation peut-elle jouer un rôle préventif ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé métabolique, mais ne prévient pas directement."
}
},
{
"@type": "Question",
"name": "Des dépistages réguliers sont-ils conseillés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dépistages peuvent être recommandés pour les individus à risque ou avec des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations ne préviennent pas les déficiences enzymatiques, mais protègent contre d'autres maladies."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les déficiences en N-terminal acetyltransferases ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent inclure des thérapies enzymatiques et des approches diététiques."
}
},
{
"@type": "Question",
"name": "Les suppléments nutritionnels peuvent-ils aider ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains suppléments peuvent soutenir le métabolisme et compenser les déficiences."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais elle pourrait offrir des solutions futures."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils améliorer la fonction enzymatique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments expérimentaux visent à améliorer l'activité des enzymes déficientes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements symptomatiques disponibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements symptomatiques peuvent aider à gérer les manifestations cliniques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec ces déficiences ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques, métaboliques et immunitaires peuvent se développer."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de maladies associées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les déficiences peuvent augmenter le risque de maladies métaboliques et neurologiques."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement impacter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Des soins palliatifs sont-ils nécessaires ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans les cas graves, des soins palliatifs peuvent être nécessaires pour améliorer le confort."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour ces déficiences ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux et certaines mutations génétiques sont des facteurs de risque clés."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles se manifestent plus fréquemment chez les jeunes enfants."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs environnementaux peuvent interagir avec des prédispositions génétiques."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies auto-immunes peuvent augmenter le risque de dysfonction enzymatique."
}
},
{
"@type": "Question",
"name": "Le sexe a-t-il un impact sur le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent que certains troubles peuvent affecter différemment les sexes."
}
}
]
}
]
}
Cesium-137, discharged by nuclear installations under normal operations and deposited in watersheds following atmospheric testing and accidents (i.e. Chernobyl, Fukushima …), has been studied for deca...
As a class of biologically active molecules with significant immunomodulatory and anti-inflammatory effects, anti-inflammatory peptides have important application value in the medical and biotechnolog...
To investigate the utility and generalizability of deep learning subtraction angiography (DLSA) for generating synthetic digital subtraction angiography (DSA) images without misalignment artifacts....
DSA images and native digital angiograms of the cerebral, hepatic, and splenic vasculature, both with and without motion artifacts, were retrospectively collected. Images were divided into a motion-fr...
Compared with the traditional DSA method, the proposed approach was found to generate synthetic DSA images with significantly fewer background artifacts (a mean rating of 1.9 [95% CI, 1.1-2.6] vs 3.5 ...
DLSA successfully generates synthetic angiograms without misalignment artifacts, is improved through transfer learning, and generalizes reliably to novel vasculature that was not included in the train...
Optical character recognition (OCR) can be a subcategory of graphic design that involves extracting text from images or scanned documents. We have chosen to make unique handwritten digits available on...
In recent years, deep learning has emerged as a highly active research field, achieving great success in various machine learning areas, including image processing, speech recognition, and natural lan...
We adopt convolutional neural networks (CNN) to predict the basic properties of the porous media. Two different media types are considered: one mimics the sand packings, and the other mimics the syste...
Advances in high-throughput DNA synthesis and sequencing have fuelled the use of massively parallel reporter assays for strain characterization. These experiments produce large datasets that map DNA s...
To determine whether nailfold capillary images, acquired using video capillaroscopy, can provide diagnostic information about diabetes and its complications....
Nailfold video capillaroscopy was performed in 120 adult patients with and without type 1 or type 2 diabetes, and with and without cardiovascular disease. Nailfold images were analyzed using convoluti...
A total of 5236 nailfold images were acquired from 120 participants (mean 44 images per participant) and were all available for analysis. Models were able to accurately identify the presence of diabet...
This proof-of-concept study demonstrates the potential of machine learning for identifying people with microvascular capillary changes from diabetes based on nailfold images, and for possibly identify...
Computational cytology is a critical, rapid-developing, yet challenging topic in medical image computing concerned with analyzing digitized cytology images by computer-aided technologies for cancer sc...
The visual inspection of coronary artery stenosis is known to be significantly affected by variation, due to the presence of other tissues, camera movements, and uneven illumination. More accurate and...